Predominance of Testosterone may Predict Heart Disease During Menopause

A new study conducted by scientists at Rush University Medical Center suggests that testosterone predominance may be a pathway by which cardiovascular disease increases during menopause.

Scientists at Rush University Medical Center are reporting in a new study that testosterone predominance may predict cardiovascular disease risk during menopause.

The study has revealed that the prevalence of metabolic syndrome, which has been linked to the development of cardiovascular disease and diabetes, increases when testosterone progressively dominates the hormonal milieu during the menopausal transition

About Hot Flash
The frequency of the hot flash can be from 1 to 2 two hot flashes a week to 10 or greater in a day. The silver lining is that it usually decreases over time.

The longitudinal, 9-year-study of 949 participants in the Study of Women's Health Across the Nation (SWAN) shows that the incidence of metabolic syndrome increased progressively from six years before to six years after the final menstrual period, independent of aging and other known cardiovascular disease risk factors.

Writing about their observations in the Archives of Internal Medicine, one of the JAMA/Archives journals, the researchers said that the increase was steeper during the menopausal transition compared to the post menopausal years.

"Menopause-related testosterone predominance appears to be implicated as a key hormonal change that is associated with the incidence of metabolic syndrome," said lead investigator Dr. Imke Janssen, assistant professor, Department of Preventive Medicine at Rush University Medical Center.

Andropause - Male menopause - Symptoms - Causes - Diagnosis - Treatment
Andropause or male menopause causing low libido in a man is due to decreasing level of male hormones, like testosterone. Symptoms of andropause are depression, irritability.

It was previously thought that oestrogen exerted a direct positive effect on cardiovascular disease risk in women, a benefit that was lost as women transitioned from a pre-menopausal to a postmenopausal state and experienced a loss of oestrogen.

"Our study data shows that the change in estrogen level is, at best, a weak and nonsignificant predictor of metabolic syndrome risk. A more likely story is that the progressive testosterone predominance exerts a direct negative effect on cardiovascular risk," said Janssen.

UK Midwife Zita West Seeks to Make Menopause Transition Smooth
UK Midwife Zita West launches menopause programme to help women cope with the transition better.

The SWAN study is a multiethnic, community-based, longitudinal cohort study of the natural history of the menopausal transition in over 3300 women enrolled in seven sites throughout the United States.

Source-ANI
RAS/L

Postmenopausal Women- Watch Your Sleep!
Postmenopausal women whose nap time exceed nine hours may be at an increased risk of ischemic stroke, according to a new study published in Journal of the American Heart Association.